NGL Fine-Chem Ltd

NGLFINE

Company Profile

  • Business description

    NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.

  • Contact

    301, E Square, Subhash Road
    Vile Parle (East)
    MumbaiMH400057
    IND

    T: +91 2240842222

    https://www.nglfinechem.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2026

    Employees

    523

Stocks News & Analysis

stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.
stocks

New production imminent for undervalued ASX gas play

LNG project receives first commissioning gas.
stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,324.6040.800.44%
CAC 408,201.9827.780.34%
DAX 4024,226.46395.471.66%
Dow JONES (US)46,469.36278.750.60%
FTSE 1009,405.2050.630.54%
HKSE25,858.83611.732.42%
NASDAQ22,915.18235.211.04%
Nikkei 22549,185.501,603.353.37%
NZX 50 Index13,344.9655.750.42%
S&P 5006,715.4551.440.77%
S&P/ASX 2009,031.9043.700.49%
SSE Composite Index3,863.8924.140.63%

Market Movers